Grapevine, TX, United States of America

Michael A Mong

USPTO Granted Patents = 3 

Average Co-Inventor Count = 4.2

ph-index = 1


Years Active: 2024

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Michael A Mong: Innovator in Medical Technology

Introduction

Michael A Mong is a notable inventor based in Grapevine, TX (US). He has made significant contributions to the field of medical technology, particularly in the treatment of viral infections. With a total of 3 patents to his name, Mong's work reflects his commitment to advancing healthcare solutions.

Latest Patents

One of Mong's latest patents focuses on forceps and systems and methods for treating coronavirus. This innovative approach includes methods of treatment for subjects who are at risk of or currently have a viral infection, specifically targeting the SARS-CoV-2 virus. The methods involve the administration of various compounds, including 4-methylumbelliferone (4-MU), palmitoylethanolamide (PEA), resveratrol, and fisetin, among others. Additionally, the patent outlines a respiratory assistance device and methods for generating customized devices to treat coronavirus infections effectively.

Career Highlights

Throughout his career, Michael A Mong has demonstrated a strong dedication to improving medical technologies. His innovative patents have the potential to significantly impact the treatment of viral infections, showcasing his expertise and forward-thinking approach in the medical field.

Collaborations

Mong has collaborated with talented individuals such as Karanjit S Kooner and Ghadeer Al-Humimat. These partnerships have likely contributed to the development and refinement of his innovative ideas and patents.

Conclusion

Michael A Mong stands out as a prominent inventor in the realm of medical technology, particularly with his recent advancements in treating viral infections. His work continues to inspire and pave the way for future innovations in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…